Bossi G, Gerry AB, Paston SJ, Sutton DH, Hassan NJ, Jakobsen BK. Examining the presentation of tumor-associated antigens on peptide- pulsed T2 cells. Oncoimmunology 2013;2:e26840.Bossi G, Gerry AB, Paston SJ, Sutton DH, Hassan NJ, Jakobsen BK. Examining the presentation of tumor-...
A1278–286 (pMAGE-A1278–286 peptide pulsed T2 cells) and U251 (HLA-A2+, MAGE-A1+) at an effector:target ratio of 40:1, and approximately 5% cytolysis against T2pHIV, A172 (HLA-A2−, MAGE-A1+), K562 and T2 cells without being pulsed with peptide at any effector:target ratio...
(HLA-A2+, MAGE-A1+) at an effector:target ratio of 40:1, and approximately 5% cytolysis against T2pHIV, A172 (HLA-A2-, MAGE-A1+), K562 and T2 cells without being pulsed with peptide at any effector:target ratio.The specific killing activity of the induced CTLs against T2pMAGE-A...
InductionofCytotoxicTLymphocytesSpecifictoMalignantGliomaUsingT2CellsPulsedwithHLA-A2-restrictedInterleukin-13Receptor~2Peptideinvitro 生物化学与生物物理学报(英文)XiaobingJIANGXiaolingLURu'enLIUFangchengZHANGHongyangZHAO